IRIS

1,3-Butadiene

CASRN 106-99-0

On this page:

MUTAGENICITY AND CARCINOGENICITY ASSESSMENT OF 1,3-BUTADIENE. REVIEW DRAFT

Notice - This site contains archived material(s).

Archive disclaimer
Archived files are provided for reference purposes only. The file was current when produced, but is no longer maintained and may now be outdated. Persons with disabilities having difficulty accessing archived files may contact the Risk Webmaster for assistance. Please use the contact form if you need additional assistance.

Overview

The Mutagenicity and Carcinogenicity Assessment of 1,3-Butadiene was prepared to serve as a source document for Agency-wide use. In the development of this assessment document, the scientific literature has been inventoried, key studies have been evaluated, and the summary and conclusions have been prepared so that the mutagenicity, carcinogenicity, and related characteristics of 1,3-butadiene are qualitatively identified. Measures of dose-response relationships relevant to ambient exposures are also discussed so that the adverse health responses are placed in perspective with possible exposure levels.

Citation

U.S. EPA. MUTAGENICITY AND CARCINOGENICITY ASSESSMENT OF 1,3-BUTADIENE. REVIEW DRAFT. U.S. Environmental Protection Agency, Washington, D.C., EPA/600/8-85/004A (NTIS PB85181097).

Top of Page

Download(s)

If you have a disability and the format of any material on our web pages interferes with your ability to access the information, please reach out to us using the Contact us about IRIS form for assistance. To enable us to respond in a manner most helpful to you, please indicate the nature of the accessibility problem, the web address of the requested material, your preferred format in which you want to receive the material (electronic format (ASCII, etc.), standard print, large print, etc.), and your contact information.

Top of Page